Provided by Tiger Trade Technology Pte. Ltd.

Boston Scientific

69.78
+1.632.39%
Pre-market: 69.77-0.0100-0.01%08:27 EDT
Volume:9.44M
Turnover:656.00M
Market Cap:103.44B
PE:35.97
High:70.10
Open:69.00
Low:68.60
Close:68.15
52wk High:109.50
52wk Low:67.56
Shares:1.48B
Float Shares:1.48B
Volume Ratio:0.73
T/O Rate:0.64%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.94
EPS(LYR):1.94
ROE:12.45%
ROA:5.98%
PB:4.27
PE(LYR):35.97

Loading ...

Boston Scientific Targets Obesity Growth With New OverStitch NXT ESG Trial in Asia

TIPRANKS
·
Jan 28

Boston Scientific Builds Neurovascular Scale With US$14.5b Penumbra Deal

Simply Wall St.
·
Jan 27

BUZZ-Citi bullish on European pharma; AstraZeneca, Novartis top picks

Reuters
·
Jan 27

Boston Scientific Corp. Stock Underperforms Monday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Jan 27

Boston Scientific call volume above normal and directionally bullish

TIPRANKS
·
Jan 27

Analysts Offer Insights on Healthcare Companies: Sarepta Therapeutics (SRPT), Boston Scientific (BSX) and Brookdale Senior Living (BKD)

TIPRANKS
·
Jan 26

A Look At Boston Scientific (BSX) Valuation As Long Term Gains Meet Recent Share Price Cooling

Simply Wall St.
·
Jan 25

Our Boston Scientific Pick Has Stumbled. Acquiring Penumbra Will Help the Stock. -- Barrons.com

Dow Jones
·
Jan 24

Boston Scientific Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jan 24

Boston Scientific Advises Removal Of Certain AXIOS Stents After Deployment Issues Surface

Benzinga_recent_news
·
Jan 22

Boston Scientific’s Big Bets On Growth Versus Valuation In Focus

Simply Wall St.
·
Jan 21

Analysts’ Opinions Are Mixed on These Healthcare Stocks: TransMedics Group (TMDX), Beam Therapeutics (BEAM) and Boston Scientific (BSX)

TIPRANKS
·
Jan 21

Boston Scientific Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jan 21

Boston Scientific Advances CHORUS IDx: New Imaging Study Targets Smarter Atrial Ablation

TIPRANKS
·
Jan 21

Boston Scientific Unveils Long-Term Spinal Cord Stimulation Data at NANS 2026

Reuters
·
Jan 20

Penumbra: Rating Cut to Hold as Boston Scientific Takeout Caps Upside at $374 Deal Price

TIPRANKS
·
Jan 20

Boston Scientific: Undervalued Ahead of Strong Q4 Results, 2026 Outlook, and PEN Acquisition Catalyst

TIPRANKS
·
Jan 17

Boston Scientific Corp. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
Jan 17

BUZZ-Truist Securities downgrades Penumbra on Boston Scientific's $14.5 billion buyout

Reuters
·
Jan 17

Boston Scientific Corp. : Oppenheimer Cuts Target Price to $100 From $125

THOMSON REUTERS
·
Jan 16